Second-line Treatment Strategy in Unresectable Hepatocellular Carcinoma After First-line Atezolizumab Plus Bevacizumab. Mohri K, Nagai H, Matsuda T, Igarashi Y, et al. Anticancer Res 2024;44:3919-3929.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mohri K, Nagai H, Matsuda T, Igarashi Y, et al. Second-line Treatment Strategy in Unresectable Hepatocellular Carcinoma After First-line Atezolizumab Plus Bevacizumab. Anticancer Res 2024;44:3919-3929.
PMID: 39197925